Company · CIK 1833214
SAB Biotherapeutics, Inc.
| CIK | 1833214 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | FL |
| Listed | SABS (Nasdaq), SABSW (Nasdaq) |
| First annual or quarterly report | 2021-04-02 |
Offerings
10 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-292482 | 2025-12-29 | 2026-03-19 | 4 | |
| 333-289992 | 2025-09-02 | 2025-09-30 | 2 | |
| 333-271768 | 2023-05-09 | 2024-01-26 | 3 | |
| 333-275319 | 2023-11-03 | 2023-11-28 | 2 | |
| 333-274119 | 2023-08-21 | 2023-08-30 | 2 | |
| 333-267012 | 2022-08-23 | 2023-06-21 | 2 | |
| 333-271543 | 2023-05-01 | 2023-05-09 | 2 | |
| 333-269565 | 2023-02-03 | 2023-02-10 | 2 | |
| 333-261496 | 2021-12-03 | 2023-02-08 | 4 | |
| 333-251178 | 2020-12-07 | 2021-01-12 | 5 |
Filings
29| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-19 | 424B5Shelf takedown | 333-292482 | 0001193125-26-114728 |
| 2026-03-17 | 424B5Shelf takedown | 333-292482 | 0001193125-26-110666 |
| 2026-01-07 | EFFECTDeclared effective | 333-292482 | 9999999995-26-000101 |
| 2025-12-29 | S-3Shelf registered | 333-292482 | 0001193125-25-335445 |
| 2025-09-30 | EFFECTDeclared effective | 333-289992 | 9999999995-25-003220 |
| 2025-09-02 | S-3Shelf registered | 333-289992 | 0001833214-25-000011 |
| 2024-01-26 | 424B5Shelf takedown | 333-271768 | 0000950170-24-007904 |
| 2023-11-28 | EFFECTDeclared effective | 333-275319 | 9999999995-23-003472 |
| 2023-11-03 | S-3Shelf registered | 333-275319 | 0000950170-23-058898 |
| 2023-08-30 | EFFECTDeclared effective | 333-274119 | 9999999995-23-002536 |
| 2023-08-21 | S-3Shelf registered | 333-274119 | 0001437749-23-024291 |
| 2023-06-21 | RWWithdrawn | 333-267012 | 0001437749-23-017991 |
| 2023-05-17 | EFFECTDeclared effective | 333-271768 | 9999999995-23-001464 |
| 2023-05-09 | EFFECTDeclared effective | 333-271543 | 9999999995-23-001353 |
| 2023-05-09 | S-3Shelf registered | 333-271768 | 0001437749-23-013303 |
| 2023-05-01 | S-3Shelf registered | 333-271543 | 0001437749-23-011878 |
| 2023-02-10 | EFFECTDeclared effective | 333-269565 | 9999999995-23-000384 |
| 2023-02-08 | EFFECTDeclared effective | 333-261496 | 9999999995-23-000316 |
| 2023-02-03 | S-3Shelf registered | 333-269565 | 0001437749-23-002490 |
| 2022-08-23 | S-1Registration filed | 333-267012 | 0001193125-22-226637 |
| 2022-04-26 | EFFECTDeclared effective | 333-261496 | 9999999995-22-001086 |
| 2021-12-15 | EFFECTDeclared effective | 333-261496 | 9999999995-21-004712 |
| 2021-12-03 | S-1Registration filed | 333-261496 | 0001493152-21-030474 |
| 2021-09-22 | EFFECTDeclared effective | 333-258869 | 9999999995-21-003620 |
| 2021-01-12 | 424B4Final prospectus | 333-251178 | 0001493152-21-000839 |
| 2021-01-11 | EFFECTDeclared effective | 333-251178 | 9999999995-21-000106 |
| 2021-01-07 | S-1/AAmendment | 333-251178 | 0001493152-21-000441 |
| 2021-01-04 | S-1/AAmendment | 333-251178 | 0001493152-21-000090 |
| 2020-12-07 | S-1Registration filed | 333-251178 | 0001493152-20-023047 |